tradingkey.logo
tradingkey.logo
Search

Denmark shares lower at close of trade; OMX Copenhagen 20 down 2.82%

Investing.comNov 12, 2024 5:00 PM
facebooktwitterlinkedin
View all comments0

Investing.com – Denmark equities were lower at the close on Tuesday, as losses in the Healthcare, Oil&Gas and Financials sectors propelled shares lower.

At the close in Copenhagen, the OMX Copenhagen 20 fell 2.82%.

The biggest gainers of the session on the OMX Copenhagen 20 were Pandora A/S (CSE:PNDORA), which rose 1.67% or 18.00 points to trade at 1,094.50 at the close. AP Moeller - Maersk A/S A (CSE:MAERSKa) fell 0.95% or 100.00 points to end at 10,450.00 and Demant A/S (CSE:DEMANT) was down 1.04% or 2.80 points to 265.40 in late trade.

Biggest losers included Zealand Pharma A/S (CSE:ZELA), which lost 5.01% or 44.00 points to trade at 833.50 in late trade. GN Store Nord (CSE:GN) declined 3.29% or 4.70 points to end at 138.00 and Novo Nordisk A/S Class B (CSE:NOVOb) shed 3.23% or 25.00 points to 748.90.

Declining stocks outnumbered rising ones by 93 to 30 and 26 ended unchanged on the Copenhagen Stock Exchange.

In commodities trading, Crude oil for December delivery was up 0.81% or 0.55 to $68.59 a barrel. Meanwhile, Brent oil for delivery in January rose 0.71% or 0.51 to hit $72.34 a barrel, while the December Gold Futures contract fell 0.41% or 10.80 to trade at $2,606.90 a troy ounce.

USD/DKK was up 0.47% to 7.03, while EUR/DKK unchanged 0.01% to 7.46.

The US Dollar Index Futures was up 0.47% at 105.96.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.